These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32317400)

  • 41. Adjunctive modafinil in ALS.
    Sternbach H
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):239. PubMed ID: 11983803
    [No Abstract]   [Full Text] [Related]  

  • 42. Preface: the state of the science of all motor neuron diseases.
    Weiss MD; Carter GT
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):xix-xx. PubMed ID: 18625405
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pharmacotherapy of amyotrophic lateral sclerosis].
    Jokelainen M
    Duodecim; 1997; 113(6):513-6. PubMed ID: 11370073
    [No Abstract]   [Full Text] [Related]  

  • 44. [Tolerance of riluzole in a phase IIIb clinical trial].
    Lacomblez L; Dib M; Doppler V; Faudet A; Robin V; Salachas F; Bensimon G; Meininger V
    Therapie; 2002; 57(1):65-71. PubMed ID: 12090150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary toxicity by riluzole.
    González-Fernández C; Güell R; Anton A
    Med Clin (Barc); 2017 Dec; 149(12):561-562. PubMed ID: 28864086
    [No Abstract]   [Full Text] [Related]  

  • 46. Amyotrophic lateral sclerosis, excitotoxicity and riluzole.
    Obrenovitch TP
    Trends Pharmacol Sci; 1998 Jan; 19(1):9-11. PubMed ID: 9509893
    [No Abstract]   [Full Text] [Related]  

  • 47. Any placebo controlled trial of riluzole would surely be unethical now.
    Ford M; Leperlier C
    BMJ; 2001 Sep; 323(7312):573-4. PubMed ID: 11573491
    [No Abstract]   [Full Text] [Related]  

  • 48. Therapies in amyotrophic lateral sclerosis-beyond riluzole.
    Morrison KE
    Curr Opin Pharmacol; 2002 Jun; 2(3):302-9. PubMed ID: 12020475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Riluzole does not improve lifespan or motor function in three ALS mouse models.
    Hogg MC; Halang L; Woods I; Coughlan KS; Prehn JHM
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):438-445. PubMed ID: 29221425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I; Camu W; Hillaire-Buys D
    Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole.
    Ceccanti M; Onesti E; Rubino A; Cambieri C; Tartaglia G; Miscioscia A; Frasca V; Inghilleri M
    Brain Stimul; 2018; 11(4):775-781. PubMed ID: 29459142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis.
    Wicks P; Ganesalingham J; Collin C; Prevett M; Leigh NP; Al-Chalabi A
    Amyotroph Lateral Scler; 2007 Jun; 8(3):177-9. PubMed ID: 17538780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ALS and myasthenia: An unusual association in a patient treated with riluzole.
    Restivo DA; Bianconi C; Ravenni R; De Grandis D
    Muscle Nerve; 2000 Feb; 23(2):294-5. PubMed ID: 10639627
    [No Abstract]   [Full Text] [Related]  

  • 54. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course.
    Cetin H; Rath J; Füzi J; Reichardt B; Fülöp G; Koppi S; Erdler M; Ransmayr G; Weber J; Neumann K; Hagmann M; Löscher WN; Auff E; Zimprich F
    Neuroepidemiology; 2015; 44(1):6-15. PubMed ID: 25571962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging.
    Kalra S; Tai P; Genge A; Arnold DL
    J Neurol; 2006 Aug; 253(8):1060-3. PubMed ID: 16609809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stage-specific riluzole effect in amyotrophic lateral sclerosis: a retrospective study.
    Thakore NJ; Lapin BR; Pioro EP;
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):140-143. PubMed ID: 31450993
    [No Abstract]   [Full Text] [Related]  

  • 59. The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.
    Meininger V; Dib M; Aubin F; Jourdain G; Zeisser P
    J Neurol; 1997 May; 244 Suppl 2():S22-5. PubMed ID: 9178167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient page. Treatment and quality of life for people with ALS.
    Fletcher J
    Neurology; 2004 May; 62(10):E22-3. PubMed ID: 15159521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.